Archana S. Nagaraja - Concepedia

Author

Archana S. Nagaraja

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

, A S Nagaraja, A.S. Nagaraja, Archana Nagaraja, Archana S Nagaraja, Archana S. Nagaraja, Archana Sidalaghatta Nagaraja, Archana S. Nagaraja, Archana Sidalaghatta Nagaraja, Choi, Hyun-Jin

121

Publications

4.2K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center The University of Texas Health Science Center at Houston University of Iowa University of California, Los Angeles The University of Texas Medical Branch at Galveston

About

Archana S. Nagaraja is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	1.9K
2	Natural Sciences	2	2	196
3	Social Sciences	2	2	105
4	Health Sciences	1	1	125
5	Public Health	1	1	52

Archana S. Nagaraja

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
Targeting Stromal Glutamine Synthetase in Tumors Disrupts Tumor Microenvironment-Regulated Cancer Cell Growth Lifeng Yang, Abhinav Achreja, Tsz-Lun Yeung, Cell Metabolism Oncogenic AgentMedicineCancer GrowthCancer BiologyAnti-cancer Agent	2016	429
Platelets reduce anoikis and promote metastasis by activating YAP1 signaling Monika Haemmerle, Morgan Taylor, Tony Gutschner, Nature Communications	2017	268
FABP4 as a key determinant of metastatic potential of ovarian cancer Kshipra M. Gharpure, Sunila Pradeep, Marta Sans, Nature Communications	2018	207
Src activation by β-adrenoreceptors is a key switch for tumour metastasis Guillermo N. Armaiz-Peña, Julie K. Allen, Anthony Cruz, Nature Communications Tumor BiologyMolecular PhysiologyTumour MetastasisMedicinePharmacology	2013	199
Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression Rajesha Rupaimoole, Sherry Y. Wu, Sunila Pradeep, Nature Communications Hypoxia (Medicine)Mirna BiogenesisSmall RnaMicrorna DetectionMedicine	2014	181
2′-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activity Sherry Y. Wu, Xianbin Yang, Kshipra M. Gharpure, Nature Communications Medicinal ChemistryDrug TargetingBiochemistryNatural Sciences2′-Ome-phosphorodithioate-modified Sirnas Show	2014	132
FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawal Monika Haemmerle, Justin Bottsford-Miller, Sunila Pradeep, Journal of Clinical Investigation ImmunologyPathologyTumor BiologyPlatelet ExtravasationAntiangiogenic Therapy Withdrawal	2016	125
Sustained Adrenergic Signaling Promotes Intratumoral Innervation through BDNF Induction Julie K. Allen, Guillermo N. Armaiz-Peña, Archana S. Nagaraja, Cancer Research	2018	122
A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer Sherry Y. Wu, Rajesha Rupaimoole, Fangrong Shen, Nature Communications Cancer BiologyTumor BiologyMir-192-egr1-hoxb9 Regulatory NetworkAngiogenesisMir-192 Delivery	2016	119
Long Noncoding RNA Ceruloplasmin Promotes Cancer Growth by Altering Glycolysis Rajesha Rupaimoole, Jae-Hyuk Lee, Monika Haemmerle, Cell Reports Tumor BiologyMedicineRna BiologyCancer Cell BiologyLong Non-coding Rna	2015	115

Page 1